DelveInsight has launched a new report on "Acute Coronary Syndrome (ACS) Market Insights, Epidemiology, and Market Forecast-2032”.
DelveInsight’s “Acute Coronary Syndrome (ACS) Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Acute Coronary Syndrome (ACS), historical and forecasted epidemiology as well as the Acute Coronary Syndrome (ACS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some of the key facts of the Acute Coronary Syndrome (ACS) Market Report:
- According to the studies, an estimated 5–8 million patients present to the ED annually for chest pain, and 20–25% diagnosed with Acute Coronary Syndrome
- The increase in market size is a direct consequence of the increasing incident population of ACS patients in the 7MM
- As per the studies, males are affected more as compared to females, in the case of ACS
- As per the results of Newmann et al. (2020), between 2005 and 2015, a total of 3797,546 cases of ACS were recorded. The mean age was 69 years and 36% were females
Request a sample for the Report: https://www.delveinsight.com/sample-request/acute-coronary-syndrome-market
- Acute Coronary Syndrome (ACS) market report covers a descriptive overview and comprehensive insight of the Acute Coronary Syndrome (ACS) Epidemiology and Acute Coronary Syndrome (ACS) market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
- The Acute Coronary Syndrome (ACS) market report provides insights on the current and emerging therapies.
- Acute Coronary Syndrome (ACS) market report provides a global historical and forecasted market covering drug outreach in 7MM.
- The Acute Coronary Syndrome (ACS) market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Acute Coronary Syndrome (ACS) market.
Got queries? Click here to know more about the Acute Coronary Syndrome (ACS) Market Landscape
Acute Coronary Syndrome (ACS) Overview:
According to American Heart Association, Acute Coronary Syndrome (ACS) is an umbrella term that refers to a spectrum of conditions compatible with acute myocardial ischemia and/or infarction that are usually due to an abrupt reduction in coronary blood flow. The traditional types of ACS comprise of myocardial infarction with ST-segment elevation (STEMI), which generally reflects an acute total coronary occlusion, myocardial infarction without ST-segment elevation (NSTEMI), and unstable angina (UA), with or without myocardial injury, respectively. While plaque rupture remains the most common cause of coronary thrombosis, superficial plaque erosion is recognized with increasing frequency.
Diagnosis can be made based on patient history, symptoms, electrocardiography findings, and cardiac biomarkers, which delineate between ST-elevation myocardial infarction and non-ST-elevation acute coronary syndrome. The recent focus on the treatment of ACS has centered on reducing the response of platelets to vascular injury as well as inhibiting fibrin deposition.
Acute Coronary Syndrome (ACS) Symptoms:
The symptoms of Acute Coronary Syndrome include –
- Pain in the chest, tightness, or burning
- Nausea or vomiting
- Sudden heavy sweating
- Shortness in breathing
- Dizziness
Acute Coronary Syndrome (ACS) Market
The dynamics of the Acute Coronary Syndrome (ACS) market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as Inclisiran, Clopidogrel, and others during the forecasted period 2019-2032.
Learn more by requesting for sample @Acute Coronary Syndrome (ACS) Market Landscape
Acute Coronary Syndrome (ACS) Pipeline Therapies:
- Prasugrel
- Rivaroxaban
- Clopidogrel
- Inclisiran
- Dalcetrapib
- Alirocumab SAR236553
Acute Coronary Syndrome (ACS) Pipeline Key Companies:
- Bayer
- Sanofi
- Novartis Pharmaceuticals
- Regeneron Pharmaceuticals
- Johnson & Johnson Pharmaceutical
- Duke Clinical Research
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Acute Coronary Syndrome (ACS) Patient Share (%) Overview at a Glance
5. Acute Coronary Syndrome (ACS) Market Overview at a Glance
6. Acute Coronary Syndrome (ACS) Disease Background and Overview
7. Acute Coronary Syndrome (ACS) Epidemiology and Patient Population
8. Country-Specific Patient Population of Acute Coronary Syndrome (ACS)
9. Acute Coronary Syndrome (ACS) Current Treatment and Medical Practices
10. Unmet Needs
11. Acute Coronary Syndrome (ACS) Emerging Therapies
12. Acute Coronary Syndrome (ACS) Market Outlook
13. Country-Wise Acute Coronary Syndrome (ACS) Market Analysis (2018–2030)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Acute Coronary Syndrome (ACS) Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Click here to read more about Acute Coronary Syndrome (ACS) Market Outlook 2032
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email:Send Email
Phone: +91 9568243403
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com
